Friday, 30 September 2005 (Poster Area H) 08:30-16:00

Poster Session

     The posters will be on display all day (08:30 to 16:00). The chaired discussion will be from 12:45 to 14:15 (during the lunch break).     
Smooth Muscle Cells

Moderators: A. Görlach (München, DE), I. Fleming (Frankfurt/Main, DE)

(P326) The serum- and glucocorticoid-regulated kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin.

R.S. Belaiba, T. Djordjevic, S. Bonello, F. Lang, J. Hess, A. Görlach (München and Tübingen, DE)
(P327) Arterial hypotension and vascular hypocontractility in cirrhotic rats is associated with impairment of RhoA/Rho-kinase-mediated vasocontraction.

M. Hennenberg, J. Trebicka, K. Jochem, E. Biecker, T. Sauerbruch, J. Heller (Bonn, DE)
(P328) The effects of ghrelin on adenylyl cyclase and phosphalipase C activity in rat aorta.

F. Ademoglu, N. Abacýoglu, E. Baloglu, H. Gurdal (Ankara, TR)
(P329) Transforming growth factor alpha transduces the activation of NF-kB but not ERK1/2 by high intraluminal pressure in the vascular wall.

C. Lemarie, B. Esposito, P-L. Tharaux, A. Tedgui, S. Lehoux (Paris, FR)
(P330) Role of the factor VII activating protease (FSAP) in vascular smooth muscle cell proliferation and neointima formation.

D. Sedding, J-M. Daniel, L. Muhl, H. Brunsch, K. Hersemeyer, R. Braun-Dullaeus, H. Tillmanns, B. Kemkes-Matthes, K. Preissner, S. Kanse (Gießen and Dresden, DE)
(P331) Characterisation of outward current in isolated rat coronary artery myocytes.

C. Prendergast, J. Quayle, T. Burdyga, S. Wray (Liverpool, GB)
(P332) Rac and PAK promote plasminogen activator inhibitor-1 expression and proliferation of pulmonary artery smooth muscle cells involving hypoxia-inducible factor-1.

T. Djordjevic, R.S. Belaiba, I. Diebold, T. Kietzmann, J. Hess, A. Görlach (München and Kaiserslautern, DE)
(P333) Gender differences in vascular reactivity to levosimendan in rat aortic rings.

G. Szabó, L. Seres, T. Radovits, S. Hagl (Heidelberg, DE)
(P334) Effects of rapamycin on neointimal and medial smooth muscle cells.

W. Dichtl, E-M. Stocker, Z-Q. Yan, H.F. Alber, M. Frick, J. Dulak, O. Pachinger, F. Weidinger (Innsbruck, AT; Stockholm, SE; Krakow, PL)
(P335) Inhibitors of histone deacetylation suppress the activation of the MAPK signaling and block the proliferation of human cSMC.

T. Gierse, K. Peters, H. Kneer, J. Leng, H. Eschert, F. Jesacher, P. Loidl, M. Jung, A. Skaletz-Rorowski (Münster, Mainz and Freiburg, DE; Innsbruck, AT)
(P336) The forkhead transcription factor FoxO1a regulates cellular Caveolin-1 expression: impact on apoptosis of vascular smooth muscle cells.

D. Sedding, S. Vogel, H. Tillmanns, R. Braun-Dullaeus (Gießen and Dresden, DE)
(P337) Conditional ablation of vascular smooth muscle cells: direct effects of cell death on normal arteries and in atherosclerosis.

M. Clarke, N. Figg, J. Maguire, A. Davenport, M. Goddard, T. Littlewood, M. Bennett (Cambridge, GB)
(P338) Desensitisation of the cardiac PTH-receptor contributes to the paradoxical vasoconstriction mediated by bioactive PTH-peptides.

G. Ross, A. Dolf, E. Bahner, K-D. Schlüter (Gießen, DE)
(P339) The contraction of smooth muscle cells is inhibited by interleukin-1, as detected in a three dimensional collagen gel assay.

Y. Shi, B. Li, U. Müller-Werdan, K. Werdan, H. Loppnow (Halle/Saale, DE)
(P340) Profiling of aortic smooth muscle cells gene expression during aging in rats.

S. Nadaud, L. Monnet, J-B. Michel, S. Raoux, B. Corman, F. Soubrier (Paris, FR)